中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

自身免疫性肝炎的诊断和治疗进展

郭晓笛 贾继东

引用本文:
Citation:

自身免疫性肝炎的诊断和治疗进展

详细信息
  • 中图分类号: R575.1

  • [1]Boberg KM.Prevalence and epidemiology of autoimmunehepatitis[J].Clin Liver Dis, 2002, 6∶347-359.
    [2]邱德凯, 马雄.自身免疫性肝病基础与临床[M].上海:上海科学技术出版社, 2006∶91.
    [3]姚光弼.关注我国自身免疫性肝炎的诊断和治疗[J].中华肝脏病杂志, 2005, 13 (1) ∶1-2.
    [4]Czaja AJ, Freese DK, Diagnosis and treatment of autoimmune hepa-titis[J].Hepatology, 2002, 36∶479-497.
    [5]Soloway RD.Clinical, biochemical, and histological remission of se-vere chronic active liver disease:a controlled study of treatmentsand early prognosis[J].Gastroenterology, 1972, 63∶820-833.
    [6]Murray-Lyon IM, Stern RB, Williams R.Controlled trial of predni-sone and azathioprine in active chronic hepatitis[J].Lancet, 1973, 1∶735-737.
    [7]Cook GC, Mulligan R, Sherlock S.Controlled prospective trial ofcorticosteroid therapy in active chronic hepatitis[J].Q J Med, 1971, 40∶159-185.
    [8]Roberts SK, Therneau T, Czaja AJ.Prognosis of histological cirrho-sis in type 1 autoimmune hepatitis[J].Gastroenterology, 1996, 110∶848-857.
    [9]Alvarez F, Berg PA, Bianchi FB, et al.International AutoimmuneHepatitis Group report:review of criteria for diagnosis of autoim-mune hepatitis[J].J Hepatol, 1999, 31∶929-38.
    [10]Czaja AJ, Carpenter HA.Decreased fibrosis during corticosteroidtherapy of autoimmune hepatitis[J].J Hepatol, 2004, 40∶644-650.
    [11]Aldo J, Montano-Loza.Consequences of treatment withdrawal intype 1 autoimmune hepatitis[J].Liver international, 2007, 27 (4) ∶507-515.
    [12]Czaja AJ.Sustained remission after corticosteroid therapy for type 1autoimmune hepatitis:a retrospective analysis[J].Hepatology, 2002, 35∶890-897.
    [13]Jordan J F.Autoimmune Hepatitis:effect of symptoms and cirrhosison natural history and outcome[J].Hepatology, 2005, 42∶53-62.
    [14]Kogan J.Prognosis of symptomatic versus asymptomatic autoimmunehepatitis:a study of 68 patients[J].J Clin Gastroenterol, 2002, 35∶75-81.
    [15]Vierling JM, Flores PA.Evolving new theprpies of autoimmunehepatitis[J].Clin Liver Dis, 2002, 6∶825-850.
    [16]Aldo J ML, Albert JC.Current therapy for autoimmunehepatitis[J].Gastroenterol Hepatol 2007, 14 (4) ∶202-214.
    [17]Malekzadeh R, Nasseri-Moghaddam S, Kaviani MJ, et al.Cy-closporin-A is a promising alternative to corticosteroids in autoim-mune hepatitis[J].Dig Dis Sci, 2001, 46∶1321-1327.
    [18]Alvarez F, Ciocca M, Canero-velasco C, et al.Short-term cy-closporine induces a remission of autoimmune hepatitis inchildren[J].J Hepatol, 1999, 30∶222-227.
    [19]Van Thiel DH, Wright H, Carroll P, et al.Tacrolimus:a potentialnew treatment for autoimmune chronic active hepatitis:results of anopen-label preliminary trial[J].Am J Gastroenterol, 1995, 90∶771-776.
    [20]Aqel BA, Machicao V, Rosser B, et al.Efficacy of tacrolimus inthe treatment of steroid refractory autoimmune hepatitis[J].J ClinGastroenterol, 2004, 38∶805-809.
    [21]Richardson PD, James PD, Ryder SD.Mycophenolate mofetil formaintenance of remission in autoimmune hepatitis patients resistantto or intolerant of azathioprine[J].J Hepatol, 2000, 33∶371-375.
    [22]Devlin SM, Swain MG, Urbanski SJ, et al.Mycophenolate mofetilfor the treatment of autoimmune hepatitis in patients refractory tostandard therapy[J].Can J Gastroenterol, 2004, 18∶321-326.
    [23]Nazira C, Alnoor R, Vincent G B, et al.Transplant immunosup-pressive agents in non-transplant chronic autoimmune hepatitis:the Canadian association for the study of liver experience with myco-phenolate mofetil and tacrolimus[J].Liver Int, 2005, 26∶723-727.
    [24]Westbrook RH, McFarlane EE, Karajeh M, et al.Treatment of au-toimmune hepatitis with mycophenolate mofetil[J].Gut, 2007, 56supplement2∶A135.
    [25]Johannes W, Andreas S, Stephan K, et al.Budesonide in previ-ously untreated autoimmune hepatitis[J].Liver Int, 2005, 25 (5) ∶927-934.
    [26]Antal C, Christoph R, Gerhard T, et al.Budesonide induces com-plete remission in autoimmune hepatitis[J].Worl J Gastroenterol, 2006, 12∶1362-1366.
    [27]Santos ES, Leopoldo RA, Luis E.R, et al.Successful treatment ofautoimmune hepatitis and idiopathic thrombocytopenic purpura withthe monoclonal antibody, rituximab:case report and review of theliterature[J].Liver Int, 2006, 26∶625-629.
  • 加载中
计量
  • 文章访问数:  1866
  • HTML全文浏览量:  4
  • PDF下载量:  955
  • 被引次数: 0
出版历程
  • 出版日期:  2007-06-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回